| Trial period | |||||||
---|---|---|---|---|---|---|---|---|
Enrolment | Post-allocation | Follow-up | ||||||
Timepoint | 0Â h | 6Â h | 12Â h | 24Â h | 36Â h | 48Â h | 72Â h | Days 90 and 180 |
Enrolment | ||||||||
 Eligibility screen | x |  |  |  |  |  |  |  |
 Informed consent | Trial guardian and next of kin |  |  |  |  |  |  | Patient as soon as possible |
 Randomization | x |  |  |  |  |  |  |  |
Interventions | ||||||||
 Infusion of study drug | x |  |  |  |  |  |  |  |
Assessments | ||||||||
 Biochemistrya | x | x | x | x | x | x | x |  |
 Biobank samples | x |  |  | x |  | x | x |  |
 ECG | x | x | x | x | x | x | x |  |
 Swan-Ganz-based measurements | x | x | x | x | x | x | x |  |
 Echocardiography |  |  |  | Day 1 |  |  |  | Before discharge |
 ABG and VBGb | x | x | x | x | x | x | x |  |
 SOFA score |  |  |  | x |  | x | x |  |
 CPC and mRS score |  |  |  |  |  |  |  | x |
 MoCA score |  |  |  |  |  |  |  | Only day 90 |